We are live on ! Find out more
SP

Saranac Partners Portfolio holdings

AUM $234M
1-Year Est. Return 14.11%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+14.11%
3 Year Est. Return
+62.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$296M
Cap. Flow
-$224M
Cap. Flow %
-87.55%
Top 10 Hldgs %
40.19%
Holding
237
New
7
Increased
43
Reduced
13
Closed
160

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.5M
2
CP icon
Canadian Pacific Kansas City
CP
+$5.92M
3
AMZN icon
Amazon
AMZN
+$3.65M
4
MSFT icon
Microsoft
MSFT
+$2.91M
5
AME icon
Ametek
AME
+$2.81M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$8.08M
2
PWR icon
Quanta Services
PWR
+$3.83M
3
AVGO icon
Broadcom
AVGO
+$1.59M
4
AZN icon
AstraZeneca
AZN
+$876K
5
LHX icon
L3Harris
LHX
+$600K

Sector Composition

Rank Sector Weight
1 Technology 31.75%
2 Healthcare 14.92%
3 Financials 14.06%
4 Consumer Discretionary 10.31%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLR icon
76
PUT
Digital Realty Trust
DLR
$72.9B
$32.8K 0.01%
+42
New +$6.9K
QQQ icon
77
PUT
Invesco QQQ Trust
QQQ
$481B
$26.3K 0.01%
+44
New +$27K
A icon
78
Agilent Technologies
A
$41.9B
– –
-860
Closed -$110K
ADP icon
79
Automatic Data Processing
ADP
$107B
– –
-580
Closed -$170K
ADSK icon
80
Autodesk
ADSK
$52.7B
– –
-417
Closed -$132K
AEP icon
81
American Electric Power
AEP
$67.9B
– –
-1,120
Closed -$126K
AGCO icon
82
AGCO
AGCO
$7.11B
– –
-960
Closed -$103K
AMGN icon
83
Amgen
AMGN
$225B
– –
-136
Closed -$37.3K
APPF icon
84
AppFolio
APPF
$6.97B
– –
-920
Closed -$254K
APTV icon
85
Aptiv
APTV
$10.1B
– –
-290
Closed -$25K
AZN icon
86
AstraZeneca
AZN
$246B
– –
-2,909
Closed -$876K
BABA icon
87
Alibaba
BABA
$300B
– –
-1,057
Closed -$189K
BIIB icon
88
Biogen
BIIB
$30.9B
– –
-57
Closed -$7.99K
BOTZ icon
89
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
– –
-915
Closed -$32.4K
BX icon
90
Blackstone
BX
$110B
– –
-310
Closed -$53K
C icon
91
Citigroup
C
$231B
– –
-1,365
Closed -$139K
CAH icon
92
Cardinal Health
CAH
$54.5B
– –
-600
Closed -$94.2K
CCK icon
93
Crown Holdings
CCK
$13.1B
– –
-1,410
Closed -$136K
CE icon
94
Celanese
CE
$4.75B
– –
-1,459
Closed -$61.4K
CPNG icon
95
Coupang
CPNG
$29.3B
– –
-10,760
Closed -$346K
CRM icon
96
Salesforce
CRM
$158B
– –
-168
Closed -$39.8K
DRI icon
97
Darden Restaurants
DRI
$25.9B
– –
-485
Closed -$92.3K
EEM icon
98
iShares MSCI Emerging Markets ETF
EEM
$30.4B
– –
-2,000
Closed -$107K
ELV icon
99
Elevance Health
ELV
$86.6B
– –
-355
Closed -$115K
EWJ icon
100
iShares MSCI Japan ETF
EWJ
$23.1B
– –
-1,679
Closed -$135K
2 3
4
5 6

Similar funds

BH
Burk Holdings Tulsa, Oklahoma $233M AUM 19.18% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
CF
CNA Financial Chicago, Illinois $235M AUM 3.39% 1-Year Est. Return
JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
VOMP
Vision One Management Partners Miami, Florida $232M AUM 49.23% 1-Year Est. Return
SC
SMA Capital New York $232M AUM
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return

Saranac Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Saranac Partners held 237 positions worth $256M, down 54% from $552M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Saranac Partners withdrew a net $224M in Q4 2025, closing 160 positions and reducing 13 holdings. Its most notable exit was AstraZeneca, an estimated $876K position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Saranac Partners opened a new position in Bank of America worth $7.81M.

  • Saranac Partners's largest Q4 2025 buy was Bank of America: 141,810 shares worth $7.81M.
  • Saranac Partners added most to Amazon in Q4 2025, an estimated $3.65M increase.
  • Saranac Partners's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $8.08M.
  • Saranac Partners fully exited AstraZeneca in Q4 2025, selling an estimated $876K.
  • Saranac Partners's ten largest holdings make up 40% of its $256M portfolio in Q4 2025.
  • Saranac Partners opened 7 new positions and closed 160 in Q4 2025.
  • Saranac Partners's portfolio value fell 54% quarter-over-quarter to $256M.

Based on Saranac Partners's 13F filing for Q4 2025, filed 6 Feb 2026.